#USA #New York #medical technology #Galien Foundation #Prix Galien USA

The Galien Foundation Unveils 2026 Prix Galien USA Award Nominees

On August 13, 2026, the Galien Foundation, an esteemed organization dedicated to recognizing breakthroughs in life sciences, announced the nominees for the 2026 Prix Galien USA Awards. This year’s categories spotlight innovations in digital health technology, medical advancements, and the dynamic environments that foster startup growth. The winners will be honored at a grand ceremony on October 29, 2026, at the American Museum of Natural History in New York City.

Kenneth C. Frazier, Co-Chair of the Galien Forum and member of the Prix Galien USA Awards Committee, expressed his admiration for the rapid advancements in medical technology and digital health that were showcased this year. "As we mark two decades of the Prix Galien USA Awards, we look ahead with excitement to recognize the remarkable nominees embodying the future of health care. Their innovative contributions reflect our enduring commitment to enhancing lives through scientific excellence."

The Galien Foundation has played a pivotal role in shaping the landscape of medical technology throughout the past twenty years, fostering collaboration among leaders in science and industry on pressing topics like medical innovations and equity in healthcare. Bruno Cohen, Chairman of the Foundation, commented on the significance of this year’s nominees: “Their accomplishments illustrate how scientific advancements can drastically improve health outcomes and contribute to the wellbeing of our planet.”

To be eligible for nomination, candidates must display significant potential to enhance human health. The “Best Medical Technology” nominees are required to have received U.S. Food and Drug Administration (FDA) approval for marketing within the past five years. It's important to note that sales figures are not factored into the nominating process; the focus remains on scientific merit and health impact.

Nominees for Best Digital Health Solution

This year's nominees under the Best Digital Health Solution category include:

• - Accumulus Technologies - Accumulus Platform
• - AEYE Health - AEYE-DS (Diagnostic Screening)
• - Aptar Digital Health - Migraine Buddy, integrating user-reported data with continuous biometrics
• - Beaconcure - Verify AI-Enabled Statistical Analysis Platform
• - Intellect - Global Mental Healthcare Platform powered by AI

These innovations represent just a glimpse of the transformative potential in digital healthcare solutions that aim to improve patient outcomes and access to medical resources.

Nominees for Best Medical Technology

In the realm of Medical Technology, the nominees include well-known innovators such as:

• - Abbott - AVEIR™ Dual Chamber Leadless Pacemaker System
• - Alcon - UNITY® Vitreoretinal Cataract System
• - Johnson & Johnson - Shockwave™ C2 Coronary Catheter
• - Medtronic - Symplicity Spyral™ Renal Denervation System

These products highlight advancements in surgical technologies and therapeutic devices that enhance treatment efficacy and patient safety.

Incubators, Accelerators, and Equity Nominees

Furthermore, the Incubators, Accelerators, and Equity category features organizations influencing the health technology landscape, including:

• - Mayo Clinic - Alliance for Health Care Accelerator
• - Calibr-Skaggs Institute - Innovative Medicines Drug Accelerator
• - Deep Knowledge Group - Fostering social good through technology

These initiatives aim to elevate healthcare accessibility and innovation through startup support and development.

Best Startup Nominees

Finally, the Best Startup category showcases up-and-coming companies pushing the boundaries of biopharmaceutical research:

• - AIVITA Biomedical, Inc.
• - BigHat Biosciences
• - Mammoth Biosciences, Inc.

These startups are set to redefine the future of healthcare with their cutting-edge research and development efforts.

The Galien Foundation’s Prix Galien is not just about honoring individual achievements; it is about fostering a collaborative spirit in a space that is continuously evolving. Lauded as the equivalent of a Nobel Prize for biopharmaceutical research, the Prix Galien seeks to amplify the collective endeavors driving modern healthcare forward.

As the global medical community anticipates the upcoming awards ceremony, the ripple effects of these innovations further showcase how scientific collaboration can lead to groundbreaking advancements, all aiming to save lives and enhance healthcare worldwide.

For more information about the nominees and the Galien Foundation, visit galienfoundation.org.